Large Molecules Regulated Bioanalysis

Large Molecules Regulated Bioanalysis
Product Description

Lambda provides regulated bioanalytical support for large molecules, biologics and biosimilars across clinical development. Capabilities include large-molecule PK analysis, anti-drug antibody assessment, neutralizing antibody testing, pharmacodynamic biomarkers, functional bioassays, immunogenicity assessment and analytical characterization. The platform supports biologics development through integrated analytical capabilities, including in vitro cell-based bioassays, analytical tools for PK and immunogenicity, high-resolution mass spectrometry, analytical method development and validation, and microbiological testing. These capabilities support characterization and clinical development of complex biological products.

Lambda Therapeutic Research Ltd

  • Country/Region:
    India
  • Founded:
    1999
  • On CPHI since:
    2015
  • Certificates:
    2
  • Employees:
    1000 - 4999
Company types
CMO/CDMO
Contract Research Organisation (CRO)
Primary activities
Analytical Services
Clinical Research
Contract Research Organisation
Laboratory Services
Nutraceuticals
Regulatory Affairs
Specifications
  • Selling Points
    Large-molecule bioanalysis is integrated with Lambda’s biologics and biosimilars development capabilities, providing access to analytical and clinical development expertise within one organization. The platform supports PK, ADA, NAb, PD, biomarker and functional bioanalysis, complemented by high-resolution mass spectrometry and cell-based assays. More than 1,600 validated bioanalytical assays, 3M+ sample storage capacity, 60+ deep freezers and 12 high-sensitivity LC-MS/MS platforms provide the laboratory infrastructure for regulated bioanalytical programs. The bioanalytical platform includes 1,600+ validated assays, 12 high-sensitivity LC-MS/MS systems, controlled sample storage with capacity for more than 3 million samples, 60+ deep freezers, automated sample inventory management, and capacity to analyze more than 110,000 samples per month. 
  • Supplied from
    India

Lambda Therapeutic Research Ltd

  • Country/Region:
    India
  • Founded:
    1999
  • On CPHI since:
    2015
  • Certificates:
    2
  • Employees:
    1000 - 4999
Company types
CMO/CDMO
Contract Research Organisation (CRO)
Primary activities
Analytical Services
Clinical Research
Contract Research Organisation
Laboratory Services
Nutraceuticals
Regulatory Affairs

More Products from Lambda Therapeutic Research Ltd (7)

  • Phase I-IV Clinical Trials

    Product Phase I-IV Clinical Trials

    Lambda provides clinical development services spanning Phase I through Phase IV, combining early-phase clinical research with extensive late-phase trial capabilities. 

    Early-phase expertise includes first-in-human, single and multiple ascending dose, biosimilar, drug-drug interaction, food-effe...
  • PK/PD Studies

    Product PK/PD Studies

    Lambda provides comprehensive PK/PD study capabilities across early clinical development, supported by extensive clinical research, bioanalytical, pharmacokinetic and pharmacodynamic expertise. Experience includes first-in-human, single and multiple ascending dose, food-effect, drug-drug interaction, compa...
  • Biologics CDMO

    Product Biologics CDMO

    Lambda’s Biologics CDMO capabilities support biologics and biosimilar programs across the development lifecycle, combining biologics development, analytical sciences and clinical development capabilities. Services span cell line engineering and product development, mammalian cell culture and protein purifi...
  • Laboratory Services: Bioanalytical, Biosimilars and Clinical Lab

    Product Laboratory Services: Bioanalytical, Biosimilars and Clinical Lab

    Lambda provides integrated laboratory services spanning regulated bioanalysis, biosimilar development and central clinical laboratory testing. Capabilities support clinical development through bioanalytical testing, immunogenicity assessment, biomarker analysis and clinical laboratory testing. The central...
  • Medical Imaging Analysis

    Product Medical Imaging Analysis

    Lambda provides centralized medical imaging services for clinical trials, with capabilities covering image management, centralized image review and reporting, query management and endpoint evaluation. A panel of experienced radiologists supports image assessment across multiple modalities, including OCT, F...
  • Pharmacovigilance

    Product Pharmacovigilance

    Lambda provides end-to-end drug safety and pharmacovigilance support from clinical trials through post-marketing activities. Services include ICSR case processing and electronic submissions, aggregate reports, risk management plans, literature monitoring, signal detection and management, xEVMPD compliance,...
  • Biostatistics and Data Management

    Product Biostatistics and Data Management

    Lambda provides biostatistics and clinical data management capabilities as part of its integrated clinical development model. The function supports clinical programs alongside clinical operations, medical writing, pharmacovigilance, medical imaging, laboratory services, and regulatory affairs. Data managem...

Lambda Therapeutic Research Ltd resources (3)